Australia’s active hospital-based surveillance for severe childhood disease

Paediatric Multisystem Inflammatory Syndrome (PIMS-TS, also known as Multisystem Inflammatory Syndrome in Children [MIS-C]) is a rare condition that occurs predominantly in children following COVID-191. It can cause inflammation of the heart, lungs, kidneys, brain, skin and eyes. It can be serious and require hospitalisation. We do not yet know what predisposes some children to develop PIMS-TS/MIS-C following COVID-19. PIMS-TS is estimated to occur in approximately 1 in every 2,500 children infected with SARS-CoV-2 and typically occurs 2–6 weeks after infection(2,3).

Surveillance for PIMS-TS in Australia is undertaken by the Paediatric Active Enhanced Disease Surveillance (PAEDS) network and is funded by the Department of Health. Data on this page will be updated monthly.

 

1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436879/
2. Williams P, Koirala A, Saravanos G, et al. COVID-19 in children in NSW, Australia, during the 2021 Delta outbreak: Severity and Disease spectrum. medRxiv 2021:2021.12.27.21268348. Available from: https://www.medrxiv.org/content/medrxiv/early/2021/12/29/2021.12.27.21268348.full.pdf(Accessed 8 February 2022).
3. https://pubmed.ncbi.nlm.nih.gov/34750151/